SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Davidouski SV, Ibragimova JA, Goncharik AV, Kartun LV, Leonov NN, Semiarykhina SE, Zaleskaya IS, Tretyk AN, Mikitski YM, Baikova AV. Proceedings of the National Academy of Sciences of Belarus, Medical Series 2022; 19(2): 230-239.

Copyright

(Copyright © 2022)

DOI

10.29235/1814-6023-2022-19-2-230-239

PMID

unavailable

Abstract

Laboratory blood testing is one of the most promising methods for determining the suicidal risk biomakers because some neurotransmitters and neuropeptides such as norepinephrine and serotonin can penetrate through the blood-brain barrier. Three groups were formed: the persons who used the highly lethal methods of self-harm (PUHMS); the persons who made a suicidal attempt in different ways (PSA); the persons who experienced psychosocial stress and previously did not commit suicide attempts (comparison group, GS). The content of serotonin and norepinephrine in blood plasma was determined by the enzyme immunoassay on a Stat Fax 2100 spectrophotometer. The depression severity was assessed using the Montgomery‒Asbrega scale, the motivation to commit suicide was assessed using an analog scale. The highest level of serotonin and noradrenaline was observed in the PSA; in half of this group (50 %), depression was not determined, the motivation severity was statistically significantly lower than in the PUHMS, but higher than in the GS where the noradrenaline content in the peripheral blood was significantly higher than in the PUHMS. The lowest norepinephrine level was noted in the GLIVS where the serotonin level was within the physiological norm (the mean value is 60.4 ng/ml, the physiological norm is 50-220 ng/ml). In the GS, the serotonin level was below the physiological norm (36 ng/ml), and the depression severity corresponded to the PUHMS indicators, however, in the PUHMS, persons with severe depressive disorder predominated (PUHMS - 23.1 %, GS -12.3 %). The low levels of serotonin and norepinephrine in the peripheral blood may indicate the risk of committing suicide. © 2022 Proceedings of the National Academy of Sciences of Belarus. Medical series. All rights reserved.


Language: ru

Keywords

Article; automutilation; controlled study; depression; disease severity; enzyme immunoassay; human; mental stress; Montgomery Asberg Depression Rating Scale; motivation; noradrenalin; noradrenalin blood level; norepinephrine; risk assessment; serotonin; serotonin blood level; suicidal attempt; suicidal behavior; suicide; suicide attempt

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print